Oxitec’s pioneering insect sterilisation technique could eradicate dengue fever and malaria and cut crop damage worldwide. LSIPR spoke to CEO Hadyn Parry about the company’s development and its approach to protecting its inventions.
In the past 10 years, research teams have built biomechanical body parts, printed synthetic meat and mapped the human genome. They might even have discovered the legendary Higgs boson.
But despite these advancements in science and medicine, malaria, dengue fever and crop damage caused by insects remain a growing problem.
Dengue cases have increased 30-fold since the 1960s and malaria kills more than 500,000 each year, while agricultural pests cause famines around the world. Yet there are no approved vaccines for either disease and until now, the most popular method of pest control has been spraying harmful pesticides and keeping fingers crossed.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at email@example.com.
If you have any technical issues please email tech support.
Oxitec, patents, Hadyn Parry, mosquitos